| Full text | |
| Author(s): |
Total Authors: 2
|
| Affiliation: | [1] São Paulo State University. School of Pharmaceutical Sciences. Department of Drugs and Medicines - Brasil
[2] São Paulo State University. School of Pharmaceutical Sciences. Department of Drugs and Medicines - Brasil
Total Affiliations: 2
|
| Document type: | Journal article |
| Source: | Dement. Neuropsychol.; v. 12, n. 1, p. 97-100, 2018-03-00. |
| Abstract | |
ABSTRACT An elderly patient, aged 76 years, diagnosed with dysphagia, depression, hypothyroidism, Alzheimer's disease and mild cognitive deficit, was identified with sertraline and levothyroxine- drug-related problems. Medication Therapy Management (MTM) was used to adjust therapy to the patient's needs by macerating sertraline tablets and solubilizing them in 10-30 mL of orange juice. The patient was advised to take levothyroxine after fasting. Six months later, pharmaceutical follow-up identified an increase in the Mini-Mental State Exam score from 22 to 26 and a decrease in the Clinical Dementia Rating (CDR) scale score from 1.0 to 0.5 in conjunction with mood and physical improvements, as well as a significant decrease in aggressiveness and agitation. Cognitive deficit may be a result of poor drug administration procedures, leading to drug ineffectiveness. Optimizing levothyroxine and sertraline administration, based on knowledge of their physicochemical properties, improves their clinical effectiveness, including the cognition of patients with Alzheimer's disease and dysphagia. (AU) | |
| FAPESP's process: | 14/00312-5 - Impact of pharmacotherapy management in patients with Alzheimer's Disease |
| Grantee: | Fernanda Mariana de Oliveira |
| Support Opportunities: | Scholarships in Brazil - Master |